Caribou Biosciences Raises $115M in Series C Funding

05 Mar, 2021

Caribou Biosciences Raises $115M in Series C Funding
Photo by Kelly Sikkema on Unsplash

– Caribou Biosciences, Inc., a Berkeley, California-based clinical-stage CRISPR genome editing biotechnology company, raised $115m in Series C funding.
– The round was co-led by new premier healthcare investors Farallon Capital Management, PFM Health Sciences, and Ridgeback Capital Investments.

Biotechnology Health Care North America Therapeutics
Crunchbase icon

Content report

The following text will be sent to our editors: